vs
Cellebrite DI Ltd.(CLBT)与LifeStance Health Group, Inc.(LFST)财务数据对比。点击上方公司名可切换其他公司
LifeStance Health Group, Inc.的季度营收约是Cellebrite DI Ltd.的1.3倍($382.2M vs $292.2M),LifeStance Health Group, Inc.净利率更高(3.1% vs -103.5%,领先106.5%),Cellebrite DI Ltd.自由现金流更多($60.8M vs $46.6M),过去两年Cellebrite DI Ltd.的营收复合增速更高(72.8% vs 12.8%)
Cellebrite DI Ltd.是一家总部位于以色列佩塔提克瓦的数字取证企业,为执法机构、企业及服务供应商提供数字数据的采集、审阅、分析与管理工具,旗下核心产品系列为Cellebrite UFED。
LifeStance Health Group是美国的门诊行为健康服务提供商,支持线下面诊与远程诊疗两种服务模式,业务涵盖心理咨询、精神科诊疗、经颅磁刺激(TMS)以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
CLBT vs LFST — 直观对比
营收规模更大
LFST
是对方的1.3倍
$292.2M
净利率更高
LFST
高出106.5%
-103.5%
自由现金流更多
CLBT
多$14.2M
$46.6M
两年增速更快
CLBT
近两年复合增速
12.8%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $292.2M | $382.2M |
| 净利润 | $-302.3M | $11.7M |
| 毛利率 | 84.6% | — |
| 营业利润率 | 14.1% | 4.7% |
| 净利率 | -103.5% | 3.1% |
| 营收同比 | — | 17.4% |
| 净利润同比 | — | 264.1% |
| 每股收益(稀释后) | $-1.50 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CLBT
LFST
| Q4 25 | — | $382.2M | ||
| Q3 25 | $292.2M | $363.8M | ||
| Q2 25 | $220.8M | $345.3M | ||
| Q1 25 | $89.6M | $333.0M | ||
| Q4 24 | — | $325.5M | ||
| Q3 24 | $232.1M | $312.7M | ||
| Q2 24 | $185.3M | $312.3M | ||
| Q1 24 | $71.2M | $300.4M |
净利润
CLBT
LFST
| Q4 25 | — | $11.7M | ||
| Q3 25 | $-302.3M | $1.1M | ||
| Q2 25 | $36.9M | $-3.8M | ||
| Q1 25 | $-71.4M | $709.0K | ||
| Q4 24 | — | $-7.1M | ||
| Q3 24 | — | $-6.0M | ||
| Q2 24 | $-95.2M | $-23.3M | ||
| Q1 24 | $-40.6M | $-21.1M |
毛利率
CLBT
LFST
| Q4 25 | — | — | ||
| Q3 25 | 84.6% | — | ||
| Q2 25 | 84.1% | — | ||
| Q1 25 | 85.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 83.5% | — | ||
| Q2 24 | 84.1% | — | ||
| Q1 24 | 82.6% | — |
营业利润率
CLBT
LFST
| Q4 25 | — | 4.7% | ||
| Q3 25 | 14.1% | 2.0% | ||
| Q2 25 | 12.1% | -0.9% | ||
| Q1 25 | 10.3% | 0.5% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | 7.9% | 0.0% | ||
| Q2 24 | 11.7% | -5.1% | ||
| Q1 24 | 0.2% | -5.6% |
净利率
CLBT
LFST
| Q4 25 | — | 3.1% | ||
| Q3 25 | -103.5% | 0.3% | ||
| Q2 25 | 16.7% | -1.1% | ||
| Q1 25 | -79.7% | 0.2% | ||
| Q4 24 | — | -2.2% | ||
| Q3 24 | — | -1.9% | ||
| Q2 24 | -51.4% | -7.5% | ||
| Q1 24 | -57.0% | -7.0% |
每股收益(稀释后)
CLBT
LFST
| Q4 25 | — | — | ||
| Q3 25 | $-1.50 | — | ||
| Q2 25 | $0.15 | — | ||
| Q1 25 | $-0.36 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.35 | — | ||
| Q2 24 | $-0.48 | — | ||
| Q1 24 | $-0.21 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $191.7M | $248.6M |
| 总债务越低越好 | — | $282.8M |
| 股东权益账面价值 | $336.0M | $1.5B |
| 总资产 | $690.6M | $2.2B |
| 负债/权益比越低杠杆越低 | — | 0.19× |
8季度趋势,按日历期对齐
现金及短期投资
CLBT
LFST
| Q4 25 | — | $248.6M | ||
| Q3 25 | $191.7M | $203.9M | ||
| Q2 25 | $326.1M | $188.9M | ||
| Q1 25 | $191.7M | $134.3M | ||
| Q4 24 | — | $154.6M | ||
| Q3 24 | $189.5M | $102.6M | ||
| Q2 24 | $178.6M | $87.0M | ||
| Q1 24 | $189.5M | $49.5M |
总债务
CLBT
LFST
| Q4 25 | — | $282.8M | ||
| Q3 25 | — | $284.6M | ||
| Q2 25 | — | $286.4M | ||
| Q1 25 | — | $288.2M | ||
| Q4 24 | — | $290.0M | ||
| Q3 24 | — | $287.3M | ||
| Q2 24 | — | $288.0M | ||
| Q1 24 | — | $288.8M |
股东权益
CLBT
LFST
| Q4 25 | — | $1.5B | ||
| Q3 25 | $336.0M | $1.5B | ||
| Q2 25 | $408.4M | $1.5B | ||
| Q1 25 | $336.0M | $1.5B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | $34.2M | $1.4B | ||
| Q2 24 | $-40.2M | $1.4B | ||
| Q1 24 | $34.2M | $1.4B |
总资产
CLBT
LFST
| Q4 25 | — | $2.2B | ||
| Q3 25 | $690.6M | $2.1B | ||
| Q2 25 | $787.4M | $2.1B | ||
| Q1 25 | $690.6M | $2.1B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | $532.9M | $2.1B | ||
| Q2 24 | $556.6M | $2.1B | ||
| Q1 24 | $532.9M | $2.1B |
负债/权益比
CLBT
LFST
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | — | 0.20× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | — | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $66.2M | $57.6M |
| 自由现金流经营现金流 - 资本支出 | $60.8M | $46.6M |
| 自由现金流率自由现金流/营收 | 20.8% | 12.2% |
| 资本支出强度资本支出/营收 | 1.8% | 2.9% |
| 现金转化率经营现金流/净利润 | — | 4.93× |
| 过去12个月自由现金流最近4个季度 | $172.1M | $110.0M |
8季度趋势,按日历期对齐
经营现金流
CLBT
LFST
| Q4 25 | — | $57.6M | ||
| Q3 25 | $66.2M | $27.3M | ||
| Q2 25 | $53.5M | $64.4M | ||
| Q1 25 | $10.0M | $-3.1M | ||
| Q4 24 | — | $62.3M | ||
| Q3 24 | $58.2M | $22.7M | ||
| Q2 24 | $24.6M | $44.1M | ||
| Q1 24 | $12.5M | $-21.8M |
自由现金流
CLBT
LFST
| Q4 25 | — | $46.6M | ||
| Q3 25 | $60.8M | $17.0M | ||
| Q2 25 | $47.5M | $56.6M | ||
| Q1 25 | $8.5M | $-10.3M | ||
| Q4 24 | — | $56.0M | ||
| Q3 24 | $55.3M | $17.7M | ||
| Q2 24 | $21.0M | $39.0M | ||
| Q1 24 | $11.4M | $-26.9M |
自由现金流率
CLBT
LFST
| Q4 25 | — | 12.2% | ||
| Q3 25 | 20.8% | 4.7% | ||
| Q2 25 | 21.5% | 16.4% | ||
| Q1 25 | 9.5% | -3.1% | ||
| Q4 24 | — | 17.2% | ||
| Q3 24 | 23.8% | 5.7% | ||
| Q2 24 | 11.3% | 12.5% | ||
| Q1 24 | 16.0% | -9.0% |
资本支出强度
CLBT
LFST
| Q4 25 | — | 2.9% | ||
| Q3 25 | 1.8% | 2.8% | ||
| Q2 25 | 2.7% | 2.2% | ||
| Q1 25 | 1.7% | 2.2% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | 1.3% | 1.6% | ||
| Q2 24 | 1.9% | 1.6% | ||
| Q1 24 | 1.5% | 1.7% |
现金转化率
CLBT
LFST
| Q4 25 | — | 4.93× | ||
| Q3 25 | — | 25.34× | ||
| Q2 25 | 1.45× | — | ||
| Q1 25 | — | -4.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLBT
| Subscription services | $197.2M | 67% |
| Term-license | $60.8M | 21% |
| Professional services | $23.2M | 8% |
| Other non-recurring | $11.0M | 4% |
LFST
暂无分部数据